MOH said it will provide an update when it is ready, with a decision expected to be made in 2026. Read more at ...
Lebrikizumab improved disease severity, skin clearance and symptom relief in children with moderate to severe atopic ...
Anyone with a chronic illness understands the struggle of living with a disease that is deeply unpredictable. Many such ...
Phase 3 data show lebrikizumab improves skin clearance and itch in children with moderate to severe atopic dermatitis, ...
The Mirror US on MSN
'I had cancer spreading all over my body for years - doctors thought it was eczema'
Michelle Smith was told she had eczema as a teenager, but as the years went on her skin became 'so much worse' - until ...
Eli Lilly scored $408 million in U.S. sales of eczema treatment Ebglyss in its first full year on the market in 2025. | With ...
A YOUNG dad who used a commonly prescribed cream for a year has told how he was left “screaming in agony” and bedbound for ...
The Goats Field shares the research-backed reasons goat milk skincare is gaining recognition as YUMA, United States - ...
Everyday Health on MSN
Atopic dermatitis treatment burnout is a real thing
If none of your atopic dermatitis treatments have worked, you may be experiencing burnout (or treatment fatigue). Here's what to do next.
Alphyn, a clinical-stage dermatology company developing the first Multi-Target Therapeutics (R) drug platform, announced today that it has completed enrollment in its CLEAR-AD1 Phase 2b clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results